Norge - norsk - Statens legemiddelverk

mcneil sweden ab - nikotinresinat - sugetablett, komprimert med fruktsmak - 2 mg

Norge - norsk - Statens legemiddelverk

haleon denmark aps - nikotin - munnspray, oppløsning med mintsmak - 1 mg/ dose

Den europeiske union - norsk - EMA (European Medicines Agency)

pfizer europe ma eeig - pneumococcal polysaccharide serotype 1, pneumococcal polysaccharide serotype 3, pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 5, pneumococcal polysaccharide serotype 6a, pneumococcal polysaccharide serotype 6b, pneumococcal polysaccharide serotype 7f, pneumococcal polysaccharide serotype 8, pneumococcal polysaccharide serotype 9v, pneumococcal polysaccharide serotype 10a, pneumococcal polysaccharide serotype 11a, pneumococcal polysaccharide serotype 12f, pneumococcal polysaccharide serotype 14, pneumococcal polysaccharide serotype 15b, pneumococcal polysaccharide serotype 18c, pneumococcal polysaccharide serotype 19a, pneumococcal polysaccharide serotype 19f, pneumococcal polysaccharide serotype 22f, pneumococcal polysaccharide serotype 23f, pneumococcal polysaccharide serotype 33f - pneumokokkerinfeksjoner - vaksiner - active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. se avsnitt 4. 4 og 5. 1 for informasjon om beskyttelse mot spesifikke pneumokokserotyper. apexxnar should be used in accordance with official recommendations. .

Norge - norsk - Statens legemiddelverk

viatris as - adrenalin - injeksjonsvæske, oppløsning i ferdigfylt penn - 300 mikrog

Norge - norsk - Statens legemiddelverk

viatris as - adrenalin - injeksjonsvæske, oppløsning i ferdigfylt penn - 150 mikrog

Den europeiske union - norsk - EMA (European Medicines Agency)

chiesi farmaceutici spa - koffein citrate - apnea - psychoanaleptics, - behandling av primær apnoea av premature nyfødte.

Den europeiske union - norsk - EMA (European Medicines Agency)

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Den europeiske union - norsk - EMA (European Medicines Agency)

gennisium pharma - koffein citrate - apnea - psychoanaleptics, - behandling av primær apnoea av premature nyfødte.

Norge - norsk - Statens legemiddelverk

linde gas - oksygen - medisinsk gass, kryogen - 100 %

Norge - norsk - Statens legemiddelverk

linde gas - oksygen - medisinsk gass, komprimert - 100 %